Skip to content
HomeLatest newsCaring & givingWhy Johnson & Johnson has made it a mission to improve surgical care in Africa
African Doctors

Why Johnson & Johnson has made it a mission to improve surgical care in Africa

As the G4 Alliance plans to discuss safe and affordable surgical care at the 70th annual World Health Assembly this week, a leader at the company, fresh off a trip to the continent, shares why it’s a topic that resonates at Johnson & Johnson.

A few weeks ago, I had the unique privilege of traveling to Africa to meet with Johnson & Johnson employees, government officials and other stakeholders in Accra, Ghana, and Johannesburg, South Africa.

While I travel frequently, it is always a great experience to see the work of our international employees and partners firsthand, and to see our company Credo in action. My visit to one of those partners, the Medical & Surgical Skills Institute (MSSI) in Ghana, was one of the highlights of my trip.

Suturing class

Participants in a suturing class in Ghana

According to data from Vanderbilt University Medical Center, 5 billion people—particularly in low-income and lower-middle-income countries—lack access to safe, affordable surgical and anesthesia care. And while Ghana, on average, does better than most countries in making surgery available to people who need it, it’s always crucial to keep training new health workers to help maintain the skills of people working in surgical settings.

In fact, ensuring that more people around the world have access to essential surgical care is a major component of Johnson & Johnson’s commitment to the 2030 UN Sustainable Development Goals.

To date, more than 10,500 healthcare providers have received critical skills training from MSSI, which gets supplies and funding from Johnson & Johnson.

A commitment to help improve surgical training in Africa

For more than 10 years, the company has partnered with MSSI to provide life-saving surgical training to doctors, nurses and other healthcare providers in Ghana and throughout sub-Saharan Africa. To date, more than 10,500 healthcare providers have received critical skills training from MSSI, which gets supplies and funding from Johnson & Johnson.

During my visit, I was able to observe a suturing class for nurses and midwives who came from all over Ghana, including many rural areas outside the capital of Accra. Their commitment to learning was clear: They were excited to improve their skills in a hospital setting, and looked forward to returning home to better serve their patients and share what they’d mastered alongside other nurses and midwives.

All over the world, the Credo is a force for good, driving us to ensure we make a difference in the communities in which we work around the world. My trip confirmed for me that Johnson & Johnson has an exciting opportunity to grow in sub-Saharan Africa and meet the significant burgeoning surgical—and overall healthcare—needs there for years to come.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.